Sanofi Menactra Adverse Event Reports Prompt Letter To Providers
This article was originally published in The Pink Sheet Daily
Executive Summary
At FDA's request, Sanofi Pasteur is informing customers of five reported cases of Guillain Barre syndrome that occurred after administration of the mengingococcal vaccine.
You may also be interested in...
Gardasil Safety Questions Persist Despite Assurances From FDA/CDC
Adverse event data on cases of Guillane-Barre Syndrome fuel questions about the safety of the vaccine.
Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says
Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says